Brief: Orchard Therapeutics Says Pricing Of Initial Public Offering
31/10/2018 03:17
Oct 30 (Reuters) - Orchard Therapeutics ORTX.O :
* ORCHARD THERAPEUTICS ANNOUNCES PRICING OF INITIAL PUBLIC
OFFERING
* ANNOUNCED PRICING OF ITS INITIAL PUBLIC OFFERING IN UNITED
STATES OF 14.29 MILLION AMERICAN DEPOSITARY SHARES ("ADSS") AT
PRICE OF $14.00 PER ADS
Source text for Eikon: ID:nGNX7RWFyK
Further company coverage: ORTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln